Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Rectal Cancer (LARC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07291401
What this trial is testing

Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

Who this might be right for
Rectal Cancer Patients
Zhongnan Hospital 108
Large-scale testing (Phase 3)Looking for participantsNCT07020247
What this trial is testing

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Who this might be right for
Locally Advanced Rectal Cancer (LARC)ImmunotherapyRadiotherapy+2 more
West China Hospital 184
Testing effectiveness (Phase 2)UnknownNCT05845268
What this trial is testing

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 102
Not applicableActive Not RecruitingNCT06688786
What this trial is testing

A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Not applicableNot Yet RecruitingNCT07769853
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Chemotherapy and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)5-12cm to Anal Verge
Zhejiang University 56
Not applicableLooking for participantsNCT06380101
What this trial is testing

Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)

Who this might be right for
Rectal Cancer
University of South Florida 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06832917
What this trial is testing

Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)

Who this might be right for
Rectal Cancer
Wan He 238
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06599827
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Who this might be right for
Rectal Cancer
Shanghai Zhongshan Hospital 54
Not applicableStudy completedNCT07049627
What this trial is testing

AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Ankara Etlik City Hospital 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT03840239
What this trial is testing

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Who this might be right for
Rectal CancerRectal Cancer Stage IIRectal Cancer Stage III+1 more
Sun Yat-sen University 98
Testing effectiveness (Phase 2)UnknownNCT05575635
What this trial is testing

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

Who this might be right for
Rectal Cancer
Henan Provincial People's Hospital 40
Not applicableLooking for participantsNCT07474103
What this trial is testing

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Who this might be right for
Rectal Cancer, Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 49
Testing effectiveness (Phase 2)UnknownNCT04989855
What this trial is testing

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Who this might be right for
Locally Advanced Rectal Cancer
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811076
What this trial is testing

Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Xuelei Ma MD 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07580339
What this trial is testing

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Looking for participantsNCT05245474
What this trial is testing

Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 186
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Testing effectiveness (Phase 2)UnknownNCT04423965
What this trial is testing

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

Who this might be right for
Locally Advanced Rectal Cancer
First Affiliated Hospital of Zhejiang University 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT06933251
What this trial is testing

PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Guangdong Provincial People's Hospital 30
Early research (Phase 1)Study completedNCT01589419
What this trial is testing

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
AbbVie (prior sponsor, Abbott) 32
Next Page